Wipo Re Search Collaborating To Mobilize The Power Of Intellectual Property For Global Health

WIPO Re:Search aims to catalyze the development of medical products for neglected tropical diseases, malaria and tuberculosis through innovative research partnerships and knowledge sharing.

WIPO Re:Search is a global public-private consortium that accelerates drug, vaccine, and diagnostic research and development (R&D) to address unmet medical needs for neglected infectious diseases and drive progress toward the United Nations Sustainable Development Goals. Established in 2011, WIPO Re:Search catalyzes royalty-free sharing of intellectual property—including compounds, data, clinical samples, technology, and expertise—among Consortium Members in targeted, mutually beneficial R&D collaborations. This publication contain stories of collaborations established through WIPO Re:Search from 2016 to 2019.

An overview of issues relevant to debates about solutions to global challenges, such as climate change, public health and food security.

This study has emerged from an ongoing program of trilateral cooperation between WHO, WTO and WIPO. It responds to an increasing demand, particularly in developing countries, for strengthened capacity for informed policy-making in areas of intersection between health, trade and IP, focusing on access to and innovation of medicines and other medical technologies.

WIPO Re:Search Consortium unites public and private market forces to address neglected tropical diseases (NTDs), malaria, and tuberculosis (TB) through sharing of intellectual property across sectors and geographies. To date, WIPO Re:Search has catalyzed over 150 R&D collaborations and managed capacity-building fellowships for scientists across sub-Saharan Africa and other low- and middle-income regions. This publication highlights seven exciting collaborations that are advancing solutions to help over one billion people who suffer from NTDs, malaria, and TB.

The consortium’s objective is to establish partnerships that facilitate sharing of IP assets to advance the discovery and development of new drugs, vaccines, and diagnostics for NTDs, malaria, and tuberculosis.

This study seeks to reinforce the understanding of the interplay between the distinct policy domains of health, trade and intellectual property, and of how they affect medical innovation and access to medical technologies. The second edition comprehensively reviews new developments in key areas since the initial launch of the study in 2013.

This edition of the Global Challenges In Focus series takes an in-depth look at some of WIPO Re:Search’s most promising scientific collaborations and their potential impacts – as described by the researchers and organizations involved.